Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Capital Work in Progress

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Capital Work in Progress ₹137 Cr₹64 Cr₹130 Cr₹223 Cr₹518 Cr

What is the latest Capital Work in Progress ratio of NATCO PHARMA ?

The latest Capital Work in Progress ratio of NATCO PHARMA is ₹137 Cr based on Mar2024 Consolidated results.
Year Capital Work in Progress
Mar2024₹137 Cr
Mar2023₹64 Cr
Mar2022₹130 Cr
Mar2021₹223 Cr
Mar2020₹518 Cr

How is Capital Work in Progress of NATCO PHARMA Trending?

Years Capital Work in Progress % Change
Mar2024 ₹137 Cr
113.53
Mar2023 ₹64 Cr
-50.35
Mar2022 ₹130 Cr
-42.03
Mar2021 ₹223 Cr
-56.87
Mar2020 ₹518 Cr -

Compare Capital Work in Progress of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹17,494.5 Cr -1% 7% -18.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,580.0 Cr 0.6% -0.4% 4.7% Stock Analytics
DIVIS LABORATORIES ₹180,069.0 Cr -2.2% 1.7% 47.3% Stock Analytics
CIPLA ₹119,919.0 Cr -0.2% -1.4% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹115,310.0 Cr 2.5% 4.8% 12.2% Stock Analytics
DR REDDYS LABORATORIES ₹104,402.0 Cr -2.6% -8.1% -4.9% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1%

7%

-18.8%

SENSEX

-1.4%

0.7%

2.4%


You may also like the below Video Courses